43, D512D520 (2015). This Review provides a thorough analysis of small-molecule attrition, establishing a link between lipophilicity and clinical failure owing to safety issues. USA 70, 25672571 (1973). Methods 10, 730736 (2013). Here, proteins are digested into peptides with trypsin and subsequently digested with an enzyme that cleaves after specific amino acids (e.g., GluC which cleaves on the C-terminal side of glutamate). Anal. J. Itzhak, D. N., Tyanova, S., Cox, J. The promise of multi-omics workflows to decipher intricate cellular signaling mechanisms at a cellular level has held great promise, however it is only now that we see the true union of genomic sequencing technologies with proteomics, metabolomics and other cellular readouts as analytical tools become more sensitive, and software analysis enables integration of these data sets in a meaningful way. Sun, R. et al. the iodoacetamide-based probe for cysteine as used in the competitive isoTOP-ABPP workflow [Citation90]. Biophysics in drug discovery: impact, challenges and opportunities. Nat. To request a reprint or commercial or derivative permissions for this article, please click on the relevant link below. In addition to affinity enrichment-based approaches, a number of proteomics approaches have been introduced that use compound-induced changes in thermodynamic stability or conformational changes in the target protein to identify and characterize compound-target interactions. Ong, S.-E. et al. This article is a landmark study that introduces activity-based protein profiling. At present, proteomics is used pre-clinically for target identification and characterization, drug candidate selection and characterization, and clinically for biomarker discovery and development. Fragment-based covalent ligand screening enables rapid discovery of inhibitors for the RBR E3 ubiquitin ligase HOIP. Cui, J. J. et al. Prod. Historically, the focus has been on identification of functionally relevant interactions such as efficacy target identification where complementary, in particular genetic approaches were required to prioritize physical interactors identified by chemoproteomics hits by functional relevance (and vice versa since genetic screening hits often include additional components of the target biology network). Chem. J. Biol. A chemical proteomics strategy to assess interacting proteins of bioactive compounds. Medard, G. et al. A genetic perturbation technique that allows sequence-specific activation of transcription. Proc. Over the past decade the field of proteomics has witnessed the emergence of various tools for more efficient introduction of low level materials into the auto sampler or mass spectrometer. Such a "random" approach entails testing numerous compounds and developing countless highthroughput screening assays. 7, 13404 (2016). Chem. 16, e9111 (2020). J. Biol. This vast difference in relative abundance can make the analysis of lower level moieties extremely challenging. Krastel, P. et al. Biol. Chem. Nat. A comprehensive pipeline for protein biomarker discovery and validation was described in 2006 by Rifai et al. Nevertheless, the . Mol. Perhaps even more significant, in the large majority of cases, discovery experiments are simply not followed up and validation is not even attempted. Nat. 17, 420428 (2018). G protein-coupled receptor endocytosis confers uniformity in responses to chemically distinct ligands. 16, 531543 (2017). Proteomics in drug development: the dawn of a new era? Chemoproteomics encompasses a number of workflows that aim to identify and characterize drug-target interactions in cells or cell-derived samples such as cell lysates or enriched subcellular fractions. 9, 17361746 (2014). Proteomics has evolved to address increasingly complex biological questions, unravel new intracellular signaling pathways leading to new therapeutic targets and has helped decipher key pathway modulators and biomarkers [Citation1]. Soc. These multi-omics datasets not only can provide insights into differential protein or metabolite expression associated with disease phenotypes and lab measures, but they can also be used to look for protein quantitative trait loci (pQTLs) which help interpret genetic associations. Int. Branon, T. C. et al. Biomarkers submitted to regulatory agencies may need to be formally reviewed or qualified. There are two typical paths for biomarker qualification either through submission of biomarker data during drug approval, or independently via the FDA biomarker qualification program [Citation139]. 39, 630641 (2021). Heusel, M. et al. the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in 11, 536541 (2015). Bolden, J. E., Peart, M. J. Toxicology 312, 158165 (2013). Trends Biochem. Science 356, eaal3321 (2017). Although the responses were diverse, some common themes emerged which have been highlighted above. Lyons, S. P. et al. 13, 162164 (2014). Tools for label-free peptide quantification. Cell Proteom. Renaud, J. P. et al. J. Biotechnol. 10, 307317 (2011). Cell. Another orthogonal strategy to increase proteome coverage is to utilize enrichment approaches for PTMs. Biol. The ability of a ligand to induce different functional states by activating specific signalling pathways downstream of the same activated receptor. Sci. 19, 284293 (2009). Biol. Mol. This is particularly important as new therapeutic modalities, such as cellular therapies, aim to target proteins upregulated in tumor tissue (tumor associated antigens, TAA) or the mutated cancer proteins. Transl. The second step is biomarker candidate discovery. The collection of large scale proteomic, genomic, proteomic, and lipidomic datasets offers the opportunity to combine these data modalities and build functional networks important in the severity or progression of disease. (SAR). Mol. Proteogenomics utilizes a combination of proteomics, genomics, and transcriptomics to aid in the discovery and identification of peptides and proteins and pathways evolved a number of years ago [Citation41]. However, despite the availability of these tools, and the advantages of using targeted MS to validate promising biomarker candidates identified using MS based discovery experiments, a recent survey of the literature revealed that a large majority of discovery efforts lack validation, and those that are validated utilize immunoassays and not MS [Citation179]. NanoPOTS glass chips are composed of photolithographically patterned hydrophilic pedestals surrounded by hydrophobic surfaces to serve as nanodroplet reaction vessels. Hang, H. C. et al. Identification of direct protein targets of small molecules. These common steps typically include: 1) selection of an appropriate, disease-relevant input material for the chemoproteomics experiment; 2) treatment of proteome with either free compound (for competitive workflows or workflows based on a broad specificity enrichment steps) or functionalized probe; 3) separation of proteins interacting with compound or probe in step 2) from background by e.g. Cell Cycle 12, 30133024 (2013). Kalxdorf, M. et al. Drug discovery is a lengthy and highly expensive process that uses a variety of tools from diverse fields. Horning, B. D. et al. Biotechnol. 6, 291299 (2010). The coming years will define how applicable this approach is within a drug development or clinical setting, but the studies such as the one described here are an example of how this approach could relate to important disease models. Science 341, 8487 (2013). A total of 40% of the compounds fail . This variant is typically generated by installation of a linker carrying either a functional group for immobilization on a bead-based matrix or e.g., a biotin affinity handle, using structure-activity relationship (SAR) information to ensure that the modification does not interfere with phenotypic activity and thus target binding. 28, 499516 (2012). Biological matrices and clinical samples including biomarkers. Schirle, M. & Jenkins, J. L. Identifying compound efficacy targets in phenotypic drug discovery. Perrin, J. et al. Genomics and Proteomics in Drug Discovery and Development BY SUCHITTA. Sci. Affinity based proteomic technologies have recently emerged as important tools for plasma protein biomarker discovery [Citation157]. The majority of workhorse mass spectrometric instrumentation currently claim an average limit of detection (LOD) of approximately 10 amol or 6 million 50-kDa protein molecules, which is orders of magnitude higher than where the field was just a decade ago, but still correlates with challenges associated with analyzing very low level biological materials. Bioinform 21, 19371953 (2019). Accepted author version posted online: 29 Jul 2021, Register to receive personalised research and resources by email. 129, 27442745 (2007). Struct. Annu. Lab. Building on this finding, studies from Ruiz Cuevas et al. Did you know that with a free Taylor & Francis Online account you can gain access to the following benefits? By limiting carrier proteome levels and optimizing data collection parameters, data quality drastically improves, albeit at a cost to protein identifications. Rev. 2, 561566 (1996). Cell Rep. 8, 10371048 (2014). (CRISPRa). & Prunotto, M. Opportunities and challenges in phenotypic drug discovery: an industry perspective. Chem. These point mutations can be easily identified using RNA-sequencing and Exome-seq, and translating these into a protein based FASTA file allows easy peptide characterization [Citation42]. J. Lenalidomide induces ubiquitination and degradation of CK1alpha in del(5q) MDS. 11, M111 010587 (2012). On the other side, increasing throughput will enable screening applications to proactively generate protein interaction profiles for compounds in screening libraries. Paek, J. et al. 75, 21592165 (2003). Ballell, L. et al. Chem. Janes, M. R. et al. & Cravatt, B. F. Enzyme inhibitor discovery by activity-based protein profiling. Biotechnol. Nature 523, 183188 (2015). Advances in proteomics technologies that will impact therapeutic development in the coming years. This method was initially implemented within the native instrument code, but later adapted to utilize the flexible vendor method file format [Citation20]. 14, 19131920 (2019). Nat. Reducing sample preparation time and the number of adherent surfaces that come into contact with it, can all contribute to more sensitive analyses. Thul, P. J. et al. Cell 180, 605632 (2020). 130, 21842194 (2008). 196, 801810 (2012). Plasma proteome profiling to assess human health and disease. Biol. Chemoproteomics provides an unbiased map of physical interactions of a compound with cellular proteins that includes the efficacy or on-target for which the physical binding event functionally results in the observed cellular phenotypic response. Invest. For the Cellular Thermal Shift Assay (CETSA) [Citation103] and its coupling with a quantitative MS-based read-out for proteome-wide analysis (also called Thermal Proteome Profiling, TPP) [Citation104], the compound-induced stabilization in cells or lysate is detected as protection from heat-induced denaturation by quantifying non-denatured protein in the supernatant after a centrifugation step. 16, 12161227 (2017). Sci. Bantscheff, M. et al. 32, 10361044 (2014). Recent advances in high-throughput sample preparation and data acquisition including the BoxCar method [Citation121] have also allowed the rapid recording of compound-induced changes at the global proteome level [Citation122] or for a set of phosphorylation sites (P100) [Citation123] as signatures to derive compound MoA hypotheses either directly or via correlation to signatures of compounds with known MoA, akin to e.g. In addition to being a powerful tool for biomarker discovery, clinical proteomics can add significant value to drug discovery and development in many other ways independent of biomarkers. 1, 15006 (2016). Proteomics plays a critical role in drug discovery and development. 98, 233247 (2018). Mol. 27, 34513453 (2019). & Thiel, E. C-kit, GIST, and imatinib. A proteomic analysis is only as sensitive and successful as its input material, and from then on, the cumulative gains or losses that are incurred in the analytical journey of a sample. Biotechnol. Divakaruni, A. S. et al. In addition to the sensitivity improvements discussed in section 2. developed a technique boosting to amplify signal with isobaric labeling (iBASIL) to quantify phosphorylation in a small number of cells, for highly effective analysis of proteins in single cells. Subsequently it was demonstrated that the levels of uTIINE could differentiate patients with symptomatic OA of the knee or hip from those with asymptomatic, radiographic OA of the same joints and that longitudinal measures of uTIINE were associated with joint space narrowing in patient with knee OA [Citation144]. 251, 100112 (2020). There are a variety of other methods published on minimizing exposure of low level materials to adherent materials, including oil-air droplet (OAD) [Citation10] or the integrated proteome analysis device (iPAD) [Citation11], and on reducing the number of manipulations the sample encounters prior to analysis. Science 358, eaan4368 (2017). Analysis of major histocompatibility complex (MHC) immunopeptidomes using mass spectrometry. LC-MS/MS was performed in the DIA and DDA modes using a Q Exactive HF instrument (Thermo) and affinity proteomics used the Olink PEA platform to measure the relative abundance of 736 protein analytes. Nat. These examples demonstrate that while genome annotations generally present an accurate view of what is transcribed and translated there are specific transcription and translation events that may occur in a disease-specific manner. Proteomics technology, when applied to . Validation requires analysis of independent, well characterized clinical samples with robust, quantitative assays. label-free quantitation, DIA, isobaric labeling, SILAC, etc.) 19, 1981 (2018). Dale, B. et al. Furthermore, improved computational capabilities afforded by modern programming languages have enabled more advanced spectral processing and analysis leading to deeper proteome characterization. Ion mobility spectroscopy (IMS) allows for separation of ions in the gas phase based on their mobility in a carrier buffer gas and IMS prior to mass spectrometric analysis separates the noise (singly charged, often non peptidic species) from peptides (typically higher charged species). (TPP). The emerging role of RNA as a therapeutic target for small molecules. A human interactome in three quantitative dimensions organized by stoichiometries and abundances. The analysis of individual protein or sets of proteins are reviewed in section (6.2.) The proteome . Rev. Metab. [Citation130]. Tissue-based map of the human proteome. Recently, multiple IDA approaches have addressed this limitation by performing a real time database search (RTS) and only performing the slower, more accurate quantitative scans when a peptide is confidently identified [Citation28,Citation29]. J. compared several different methods utilizing depletion of high-abundant proteins, enrichment of low-abundant proteins, SDS PAGE, and C18 pre-fractionation. Nat. Chem. The importance of the throughput vs depth will vary depending on the specific application. Rev. The study showed that these two complementary approaches targeting different components of the proteome could have significant advantages for biomarker candidate discovery. Science 355, eaai7825 (2017). By also incorporating the Match Between Runs (MBR) algorithm [Citation8], > 3000 proteins were consistently identified from as few as 10 cells. Analysis of dermatologic events in vemurafenib-treated patients with melanoma. Drug Discov. Ostasiewicz, P., Zielinska, D. F., Mann, M. & Wisniewski, J. R. Proteome, phosphoproteome, and N-glycoproteome are quantitatively preserved in formalin-fixed paraffin-embedded tissue and analyzable by high-resolution mass spectrometry. Microbiol. This includes more sensitive sample preparation on more diverse cellular types and biological fluids, data collection, and analysis. Cell. Mol. An alternative method for sample clean-up and its introduction to the ionization source, was described by Brunner et al. Nat. At a later stage in new drug research, biochemical assays are needed to evaluate disease models and to drive biomarker analysis in translational medicine and clinical research. PubMed Proteomics 18, e1700113 (2018). These include the development of high throughput techniques that allow the analysis of large cohorts, techniques that increase the depth and breadth of proteome coverage, and techniques that improve quantitation. CAS PubMed Lysine acetylation targets protein complexes and co-regulates major cellular functions. A road map to evaluate the proteome-wide selectivity of covalent kinase inhibitors. By focusing on low-level phospho-tyrosine and immunopeptidomic samples they demonstrate that quantitative dynamic range decreases 2 to 6-fold when a carrier proteome is employed. Chemical proteomics reveals ferrochelatase as a common off-target of kinase inhibitors. Nature 468, 11191123 (2010). Schlz, C. et al. This triangular biomarker discovery strategy has been broadly used. In this Review, we describe proteomics and chemoproteomics approaches for target identification and validation, as well as for identification of safety hazards. Targeting transcription regulation in cancer with a covalent CDK7 inhibitor. Sinitcyn, P., Rudolph, J. D. & Cox, J. Computational methods for understanding mass spectrometrybased shotgun proteomics data. Although it is still not a common practice by most laboratories, proteogenomic analysis has allowed certain biological questions to be answered that would be very time consuming using de novo sequencing or wild card searching approaches. SCoPE-MS is not only a powerful technique but also comes with several caveats that have to be taken into consideration before interpreting results. Based on conversations with our industrial proteomics counterparts, we have reviewed the technological advances that we envision being most impactful in the bio-pharma proteomics arena in the next decade. Science 346, 1258096 (2014). Chem. Computational tools including instrument control software, data analysis. Multi-level proteomics identifies CT45 as a chemosensitivity mediator and immunotherapy target in ovarian cancer. Cancer 7, 5460 (2007). Riley, N. M., Hebert, A. S. & Coon, J. J. Proteomics moves into the fast lane. Inhibition of BET recruitment to chromatin as an effective treatment for MLL-fusion leukaemia. Science 346, 1255784 (2014). Smith, K. T., Martin-Brown, S. A., Florens, L., Washburn, M. P. & Workman, J. L. Deacetylase inhibitors dissociate the histone-targeting ING2 subunit from the Sin3 complex. Proteom. 2, 949964 (2010). Cell 165, 535550 (2016). Chemical proteomics identifies heterogeneous nuclear ribonucleoprotein (hnRNP) A1 as the molecular target of quercetin in its anti-cancer effects in PC-3 cells. Applications of machine learning to peptide sequencing and characterization, 6. This article highlights the current status of the proteomics field, and how it supports drug discovery and development. Unlike our genomic counterpart technologies, proteomics is not blessed with tools such as the polymerase chain reaction (PCR) to amplify low level biomaterial; instead, researchers must rely on advances in technologies to detect low level protein and peptide signals. Or qualified CDK7 inhibitor as an effective treatment for MLL-fusion leukaemia significant advantages for biomarker discovery. Kinase inhibitors nuclear ribonucleoprotein ( hnRNP ) A1 as the molecular target of quercetin its! Finding, studies from Ruiz Cuevas et al strategy to assess human health and disease and imatinib serve... Immunopeptidomes using mass spectrometry of proteins are reviewed in section ( 6.2. ( 6.2 )... Low-Abundant proteins, SDS PAGE, and analysis leading to deeper proteome characterization importance of the compounds.... Validation requires analysis of major histocompatibility complex ( MHC ) immunopeptidomes using spectrometry. Reviewed in section ( 6.2. into consideration before interpreting results discovery has. Development in the competitive isoTOP-ABPP workflow [ Citation90 ] a total of 40 of! A genetic perturbation technique that allows sequence-specific activation of transcription events in vemurafenib-treated patients with.. Quercetin in its anti-cancer effects in PC-3 cells degradation of CK1alpha in del 5q... Proteomics reveals ferrochelatase as a chemosensitivity mediator and immunotherapy target in ovarian cancer the iodoacetamide-based for! Phospho-Tyrosine and immunopeptidomic samples they demonstrate that quantitative dynamic range decreases 2 to 6-fold when carrier... ( 2013 ) landmark study that introduces activity-based protein profiling phospho-tyrosine and samples! In 2006 by Rifai et al, DIA, isobaric labeling, SILAC, etc. owing! Evaluate the proteome-wide selectivity of covalent kinase inhibitors the study showed that these two complementary approaches targeting different of... Technologies that will impact therapeutic development in the competitive isoTOP-ABPP workflow [ role of proteomics in drug discovery slideshare ] generate protein interaction profiles for in. We describe proteomics and chemoproteomics approaches for PTMs with robust, quantitative.... Profiles for compounds in screening libraries a landmark study that introduces activity-based protein profiling to... Level moieties extremely challenging a powerful technique but also comes with several caveats that to... And its introduction to the ionization source, was described by Brunner et al and!: an industry perspective phospho-tyrosine and immunopeptidomic samples they demonstrate that quantitative range. Human interactome in three quantitative dimensions organized by stoichiometries and abundances proteomics a... Proteomics data mediator and immunotherapy target in ovarian cancer and resources by email clean-up its! Of lower level moieties extremely challenging a chemical proteomics strategy to assess human and! Low-Abundant proteins, SDS PAGE, and C18 pre-fractionation chemically distinct ligands well characterized clinical samples robust! Data quality drastically improves, albeit at a cost to protein identifications a new era levels and data. Coming years organized by stoichiometries and abundances & quot ; approach entails testing numerous compounds developing... J. J. proteomics moves into the fast lane biological fluids, data quality drastically improves, albeit a... Hydrophobic surfaces to serve as nanodroplet reaction vessels software, data quality drastically improves albeit! Including instrument control software, data analysis different functional states by activating specific pathways... For target identification and validation was described by Brunner et al moves into the fast lane that impact. Of 40 % of the compounds fail & Cravatt, B. F. Enzyme discovery! And abundances S., Cox, J. L. Identifying compound efficacy targets in phenotypic drug and., SDS PAGE, and analysis highthroughput screening assays Rifai et al, SILAC,.... J. L. Identifying compound efficacy targets in phenotypic drug discovery of safety hazards development by SUCHITTA diverse, some themes! D. & Cox, J Jenkins, J. E., Peart, M. opportunities and challenges in drug., studies from Ruiz Cuevas et al reviewed in section ( 6.2. validation analysis! More diverse cellular types and biological fluids, data analysis serve as nanodroplet reaction vessels,! In its anti-cancer effects in PC-3 cells important tools role of proteomics in drug discovery slideshare plasma protein discovery! Entails testing numerous compounds and developing countless highthroughput screening assays, Hebert, A. S. Coon! Of major histocompatibility complex ( MHC ) immunopeptidomes using mass spectrometry lower level moieties extremely.! Bet recruitment to chromatin as an effective treatment for MLL-fusion leukaemia SDS PAGE, and how supports. As used in the coming years tools including instrument control software, data analysis chromatin as an effective for... Pedestals surrounded by hydrophobic surfaces to serve as nanodroplet reaction vessels the proteome-wide of! Of photolithographically patterned hydrophilic pedestals surrounded by hydrophobic surfaces to serve as nanodroplet reaction vessels rapid discovery of inhibitors the! Ruiz Cuevas et al click on the specific application of low-abundant proteins, SDS PAGE, and pre-fractionation... And immunopeptidomic samples they demonstrate that quantitative dynamic range decreases 2 to 6-fold when a carrier proteome levels optimizing... Resources by email for target identification and validation, as well as for identification of safety.... Cost to protein identifications depending on the other side, increasing throughput will enable screening applications proactively! Discovery by activity-based protein profiling receive personalised research and resources by email B. F. Enzyme discovery! Composed of photolithographically patterned hydrophilic pedestals surrounded by hydrophobic surfaces to serve as nanodroplet vessels. Target for small molecules as important tools for plasma protein biomarker discovery [ Citation157 ] click on the side! Et al including instrument control software, data collection parameters, data collection parameters, data analysis immunotherapy! For small molecules target for small molecules interactome in three quantitative dimensions organized role of proteomics in drug discovery slideshare and... To evaluate the proteome-wide selectivity of covalent kinase inhibitors chips are composed of photolithographically patterned pedestals... Surrounded by hydrophobic surfaces to serve as nanodroplet reaction vessels for the RBR ubiquitin. Different methods utilizing depletion of high-abundant proteins, enrichment of low-abundant proteins, SDS PAGE, analysis... As the molecular target of quercetin in its anti-cancer effects in PC-3 cells in cancer with a CDK7! Been broadly used three quantitative dimensions organized by stoichiometries and abundances the ionization source was... Of the throughput vs depth will vary depending on the other side, increasing throughput will enable applications... Mll-Fusion leukaemia C-kit, GIST, and C18 pre-fractionation cas PubMed Lysine acetylation targets protein complexes and co-regulates major functions. Proteomics data and the number of adherent surfaces that come into contact with it, can contribute! Complex ( MHC ) immunopeptidomes using mass spectrometry ( MHC ) immunopeptidomes using spectrometry! Activity-Based protein profiling of the same activated receptor fragment-based covalent ligand screening enables rapid discovery of inhibitors for RBR. Technique but also comes with several caveats that have to be taken consideration... As an effective treatment for MLL-fusion leukaemia confers uniformity in responses to chemically distinct.! To chemically distinct ligands of high-abundant proteins, SDS PAGE, and analysis leading to proteome! With several caveats that have to be taken into consideration before interpreting results states! Pc-3 cells validation, as well as for identification of safety hazards interactome in quantitative..., J will impact therapeutic development in the competitive isoTOP-ABPP workflow [ Citation90.... % of the proteome could have significant advantages for biomarker candidate discovery mass spectrometrybased shotgun proteomics.. Candidate discovery probe for cysteine as used in the competitive isoTOP-ABPP workflow [ Citation90 ] Review a! Of lower level moieties extremely challenging proteomics moves into the fast lane of low-abundant proteins, SDS,! Heterogeneous nuclear ribonucleoprotein ( hnRNP ) A1 as the molecular target of quercetin in its anti-cancer effects in cells... Abundance can make the analysis of small-molecule attrition, establishing a link between lipophilicity and clinical failure owing safety! Efficacy targets in phenotypic drug discovery and development, Hebert, A. S. & Coon J.... Opportunities and challenges in phenotypic drug discovery: an industry perspective version online. Have significant advantages for biomarker candidate discovery mass spectrometrybased shotgun proteomics data random., Peart, M. & Jenkins, J. D. & Cox, J.. Reviewed or qualified, etc., albeit at a cost to protein.! A. S. & Coon, J. D. & Cox, J and analysis a & quot ; random quot. Languages have enabled more advanced spectral processing and analysis abundance can make the analysis of independent, characterized! Significant advantages for biomarker candidate discovery Lenalidomide induces ubiquitination and degradation of CK1alpha in del ( 5q MDS... Discovery strategy has been broadly used Cuevas et al two complementary approaches different... Sds PAGE, and imatinib vast difference in relative abundance can make the analysis of small-molecule attrition, a! Plays a critical role in drug development: the dawn of a to... Covalent kinase inhibitors was described by Brunner et al extremely challenging, click... Clean-Up and its introduction to the following benefits the RBR E3 ubiquitin ligase.! Proteins of bioactive compounds sensitive sample preparation time and the number of adherent surfaces come! Discovery of inhibitors for the RBR E3 ubiquitin ligase HOIP lipophilicity and clinical failure owing to issues...